MANF and Hepatic fibrosis: Notably, systemic administration of recombinant human MANF markedly alleviates CCl4-induced hepatic fibrosis in both wild-type and hepatocyte-specific MANF knockout mice by targeting TLR4/NF-κB signaling (Hou et al., 2023).